6-[3-([1]benzofuro[3,2-b]carbazol-11-yl)-5-(2-cyanophenyl)phenyl]dibenzothiophene-2-carbonitrile
C44H23N3OS — CID 139339988
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[3-([1]benzofuro[3,2-b]carbazol-11-yl)-5-(2-cyanophenyl)phenyl]dibenzothiophene-2-carbonitrile
6-[3-([1]benzofuro[3,2-b]carbazol-11-yl)-5-(2-cyanophenyl)phenyl]dibenzothiophene-2-carbonitrile (PubChem CID 139339988) has the molecular formula C44H23N3OS and a molecular weight of 641.76 g/mol. Its IUPAC name is 6-[3-([1]benzofuro[3,2-b]carbazol-11-yl)-5-(2-cyanophenyl)phenyl]dibenzothiophene-2-carbonitrile.
Molecular Properties
| Compound Name | 6-[3-([1]benzofuro[3,2-b]carbazol-11-yl)-5-(2-cyanophenyl)phenyl]dibenzothiophene-2-carbonitrile |
|---|---|
| PubChem CID | 139339988 |
| Molecular Formula | C44H23N3OS |
| Molecular Weight | 641.76 g/mol |
| Exact Mass | 641.16 |
| IUPAC Name | 6-[3-([1]benzofuro[3,2-b]carbazol-11-yl)-5-(2-cyanophenyl)phenyl]dibenzothiophene-2-carbonitrile |
| SMILES | N#Cc1ccc2sc3c(-c4cc(-c5ccccc5C#N)cc(-n5c6ccccc6c6cc7oc8ccccc8c7cc65)c4)cccc3c2c1 |
| InChI | InChI=1S/C44H23N3OS/c45-24-26-16-17-43-38(18-26)35-13-7-12-32(44(35)49-43)29-19-28(31-9-2-1-8-27(31)25-46)20-30(21-29)47-39-14-5-3-10-33(39)36-23-42-37(22-40(36)47)34-11-4-6-15-41(34)48-42/h1-23H |
| InChIKey | VJQDPDDLRQPHMY-UHFFFAOYSA-N |
| XLogP | 12.13 |
| TPSA | 65.65 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 641.76 |
| LogP ≤ 5 | 12.13 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139339988 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.